{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T22:05:30Z","timestamp":1761948330753,"version":"3.37.3"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2017,11,23]],"date-time":"2017-11-23T00:00:00Z","timestamp":1511395200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"funder":[{"DOI":"10.13039\/501100001835","name":"Maastricht University","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100001835","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Osteoporos Int"],"published-print":{"date-parts":[[2018,2]]},"DOI":"10.1007\/s00198-017-4290-y","type":"journal-article","created":{"date-parts":[[2017,11,23]],"date-time":"2017-11-23T10:20:49Z","timestamp":1511432449000},"page":"397-407","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":21,"title":["Comorbidities and medication use in patients with a recent clinical fracture at the Fracture Liaison Service"],"prefix":"10.1007","volume":"29","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6925-4397","authenticated-orcid":false,"given":"L.","family":"Vranken","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C. E.","family":"Wyers","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R. Y.","family":"Van der Velde","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H. M.","family":"Janzing","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Kaarsemaker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P. P.","family":"Geusens","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J. P.","family":"Van den Bergh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2017,11,23]]},"reference":[{"key":"4290_CR1","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1007\/s001980070064","volume":"11","author":"JA Kanis","year":"2000","unstructured":"Kanis JA, Johnell O, Oden A et al (2000) Long-term risk of osteoporotic fracture in Malm\u00f6. Osteoporos Int 11:669\u2013674. \n                    https:\/\/doi.org\/10.1007\/s001980070064","journal-title":"Osteoporos Int"},{"key":"4290_CR2","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1016\/S8756-3282(01)00614-7","volume":"29","author":"TP Staa van","year":"2001","unstructured":"van Staa TP, Dennison EM, Leufkens HGM, Cooper C (2001) Epidemiology of fractures in England and Wales. Bone 29:517\u2013522. \n                    https:\/\/doi.org\/10.1016\/S8756-3282(01)00614-7","journal-title":"Bone"},{"key":"4290_CR3","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1007\/s11657-013-0136-1","volume":"8","author":"E Hernlund","year":"2013","unstructured":"Hernlund E, Svedbom A, Iverg\u00e5rd M et al (2013) Osteoporosis in the European Union: medical management, epidemiology and economic burden. Arch Osteoporos 8:136. \n                    https:\/\/doi.org\/10.1007\/s11657-013-0136-1","journal-title":"Arch Osteoporos"},{"key":"4290_CR4","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1016\/j.bone.2004.03.024","volume":"35","author":"JA Kanis","year":"2004","unstructured":"Kanis JA, Johnell O, De Laet C et al (2004) A meta-analysis of previous fracture and subsequent fracture risk. Bone 35:375\u2013382. \n                    https:\/\/doi.org\/10.1016\/j.bone.2004.03.024","journal-title":"Bone"},{"key":"4290_CR5","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1001\/jama.297.4.387","volume":"297","author":"JR Center","year":"2007","unstructured":"Center JR, Bliuc D, Nguyen TV, Eisman JA (2007) Risk of subsequent fracture after low-trauma fracture in men and women. JAMA 297:387\u2013394. \n                    https:\/\/doi.org\/10.1001\/jama.297.4.387","journal-title":"JAMA"},{"key":"4290_CR6","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1359\/jbmr.2000.15.4.721","volume":"15","author":"CM Klotzbuecher","year":"2010","unstructured":"Klotzbuecher CM, Ross PD, Landsman PB et al (2010) Patients with prior fractures have an increased risk of future fractures: a summary of the literature and statistical synthesis. J Bone Miner Res 15:721\u2013739. \n                    https:\/\/doi.org\/10.1359\/jbmr.2000.15.4.721","journal-title":"J Bone Miner Res"},{"key":"4290_CR7","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1741-7015-4-24","volume":"4","author":"AC Geel van","year":"2006","unstructured":"van Geel AC, Geusens PP, Nagtzaam IF et al (2006) Timing and risk factors for clinical fractures among postmenopausal women: a 5-year prospective study. BMC Med 4:1\u20137. \n                    https:\/\/doi.org\/10.1186\/1741-7015-4-24","journal-title":"BMC Med"},{"key":"4290_CR8","unstructured":"Dutch Institute for Healthcare Improvement CBO (2011) Richtlijn Osteoporose en Fractuurpreventie, Derde Herziening [Dutch] Utrecht, Dutch Institute for Healthcare Improvement CBO, The Netherlands"},{"key":"4290_CR9","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1016\/j.maturitas.2013.05.013","volume":"75","author":"J Compston","year":"2013","unstructured":"Compston J, Bowring C, Cooper A et al (2013) Diagnosis and management of osteoporosis in postmenopausal women and older men in the UK: National Osteoporosis Guideline Group (NOGG) update 2013. Maturitas 75:392\u2013396. \n                    https:\/\/doi.org\/10.1016\/j.maturitas.2013.05.013","journal-title":"Maturitas"},{"key":"4290_CR10","doi-asserted-by":"publisher","first-page":"2359","DOI":"10.1007\/s00198-014-2794-2","volume":"25","author":"F Cosman","year":"2014","unstructured":"Cosman F, de Beur SJ, LeBoff MS et al (2014) Clinician\u2019s guide to prevention and treatment of osteoporosis. Osteoporos Int 25:2359\u20132381. \n                    https:\/\/doi.org\/10.1007\/s00198-014-2794-2","journal-title":"Osteoporos Int"},{"key":"4290_CR11","doi-asserted-by":"publisher","first-page":"2039","DOI":"10.1002\/jbmr.1698","volume":"27","author":"JA Eisman","year":"2012","unstructured":"Eisman JA, Bogoch ER, Dell R et al (2012) Making the first fracture the last fracture: ASBMR task force report on secondary fracture prevention. J Bone Miner Res 27:2039\u20132046. \n                    https:\/\/doi.org\/10.1002\/jbmr.1698","journal-title":"J Bone Miner Res"},{"key":"4290_CR12","doi-asserted-by":"publisher","unstructured":"Lems WF, Dreinh\u00f6fer KE, Bischoff-Ferrari H et al (2016) EULAR\/EFFORT recommendations for management of patients older than 50 years with a fragility fracture and prevention of subsequent fractures. Ann Rheum Dis. \n                    https:\/\/doi.org\/10.1136\/annrheumdis-2016-210289","DOI":"10.1136\/annrheumdis-2016-210289"},{"key":"4290_CR13","doi-asserted-by":"publisher","first-page":"2135","DOI":"10.1007\/s00198-013-2348-z","volume":"24","author":"K \u00c5kesson","year":"2013","unstructured":"IOF Fracture Working Group, \u00c5kesson K, Marsh D et al (2013) Capture the fracture: a best practice framework and global campaign to break the fragility fracture cycle. Osteoporos Int 24:2135\u20132152. \n                    https:\/\/doi.org\/10.1007\/s00198-013-2348-z","journal-title":"Osteoporos Int"},{"key":"4290_CR14","doi-asserted-by":"publisher","first-page":"1360","DOI":"10.1210\/jc.2010-2135","volume":"96","author":"SPG Bours","year":"2011","unstructured":"Bours SPG, van Geel TACM, Geusens PPMM et al (2011) Contributors to secondary osteoporosis and metabolic bone diseases in patients presenting with a clinical fracture. J Clin Endocrinol Metab 96:1360\u20131367. \n                    https:\/\/doi.org\/10.1210\/jc.2010-2135","journal-title":"J Clin Endocrinol Metab"},{"key":"4290_CR15","doi-asserted-by":"publisher","first-page":"878","DOI":"10.1016\/S0140-6736(98)09075-8","volume":"353","author":"JR Center","year":"1999","unstructured":"Center JR, Nguyen TV, Schneider D et al (1999) Mortality after all major types of osteoporotic fracture in men and women: an observational study. The Lancet 353:878\u2013882. \n                    https:\/\/doi.org\/10.1016\/S0140-6736(98)09075-8","journal-title":"The Lancet"},{"key":"4290_CR16","unstructured":"World Health Organisation (2003) Prevention and management of osteoporosis, World Health Organization Technical Report Series, vol. 921, pp. 1\u2013164"},{"key":"4290_CR17","unstructured":"World Health Organization WHO international statistical classification of diseases and related health problems 10th revision"},{"key":"4290_CR18","doi-asserted-by":"publisher","first-page":"2051","DOI":"10.1007\/s00198-011-1642-x","volume":"22","author":"D Marsh","year":"2011","unstructured":"IOF CSA Fracture Working Group, Marsh D, \u00c5kesson K et al (2011) Coordinator-based systems for secondary prevention in fragility fracture patients. Osteoporos Int 22:2051\u20132065. \n                    https:\/\/doi.org\/10.1007\/s00198-011-1642-x","journal-title":"Osteoporos Int"},{"key":"4290_CR19","unstructured":"World Health Organization (2007) WHO global report on falls prevention in older age."},{"key":"4290_CR20","unstructured":"Dutch Institute for Healthcare Improvement CBO (2004) Richtlijn Preventie van valincidenten bij ouderen [Dutch] Utrecht, Dutch Institute for Healthcare Improvement CBO, The Netherlands"},{"key":"4290_CR21","unstructured":"National Institute for Health and Care Excellence (2015) Falls in older people."},{"key":"4290_CR22","unstructured":"Panel on falls prevention, American Geriatrics Society, British Geriatrics Society, and American Academy of Orthopaedic Surgeons (2001) Guideline for the prevention of falls in older persons. J Am Geriatr Soc. 49(5):664\u201372"},{"key":"4290_CR23","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1111\/j.1532-5415.2010.03234.x","volume":"59","author":"Panel on Prevention of Falls in Older Persons, American Geriatrics Society and British Geriatrics Society","year":"2011","unstructured":"Panel on Prevention of Falls in Older Persons, American Geriatrics Society and British Geriatrics Society (2011) Summary of the updated American Geriatrics Society\/British Geriatrics Society clinical practice guideline for prevention of falls in older persons. J Am Geriatr Soc 59:148\u2013157. \n                    https:\/\/doi.org\/10.1111\/j.1532-5415.2010.03234.x","journal-title":"J Am Geriatr Soc"},{"key":"4290_CR24","unstructured":"WHO Collaborating Centre for Drug Statistics Methodology (2016) Guideline for ATC classification and DDD assignment, 20th edition"},{"key":"4290_CR25","doi-asserted-by":"publisher","first-page":"653","DOI":"10.2165\/11538200-000000000-00000","volume":"27","author":"C Sj\u00f6berg","year":"2010","unstructured":"Sj\u00f6berg C, Bladh L, Klintberg L et al (2010) Treatment with fall-risk-increasing and fracture-preventing drugs before and after a hip fracture: an observational study. Drugs Aging 27:653\u2013661. \n                    https:\/\/doi.org\/10.2165\/11538200-000000000-00000","journal-title":"Drugs Aging"},{"key":"4290_CR26","doi-asserted-by":"publisher","first-page":"1952","DOI":"10.1001\/archinternmed.2009.357","volume":"169","author":"JC Woolcott","year":"2009","unstructured":"Woolcott JC, Richardson KJ, Wiens MO et al (2009) Meta-analysis of the impact of 9 medication classes on falls in elderly persons. Arch Intern Med 169:1952\u20131960","journal-title":"Arch Intern Med"},{"key":"4290_CR27","doi-asserted-by":"publisher","first-page":"917","DOI":"10.1007\/s40266-014-0225-x","volume":"31","author":"AC Ham","year":"2014","unstructured":"Ham AC, Swart KMA, Enneman AW et al (2014) Medication-related fall incidents in an older, ambulant population: the B-PROOF study. Drugs Aging 31:917\u2013927. \n                    https:\/\/doi.org\/10.1007\/s40266-014-0225-x","journal-title":"Drugs Aging"},{"key":"4290_CR28","doi-asserted-by":"publisher","first-page":"1531","DOI":"10.1001\/jamainternmed.2016.4814","volume":"176","author":"JC Munson","year":"2016","unstructured":"Munson JC, Bynum JPW, Bell J-E et al (2016) Patterns of prescription drug use before and after fragility fracture. JAMA Intern Med 176:1531\u20131538. \n                    https:\/\/doi.org\/10.1001\/jamainternmed.2016.4814","journal-title":"JAMA Intern Med"},{"key":"4290_CR29","doi-asserted-by":"publisher","first-page":"b4229","DOI":"10.1136\/bmj.b4229","volume":"339","author":"J Hippisley-Cox","year":"2009","unstructured":"Hippisley-Cox J, Coupland C (2009) Predicting risk of osteoporotic fracture in men and women in England and Wales: prospective derivation and validation of QFractureScores. BMJ 339:b4229\u2013b4229. \n                    https:\/\/doi.org\/10.1136\/bmj.b4229","journal-title":"BMJ"},{"key":"4290_CR30","doi-asserted-by":"publisher","first-page":"1033","DOI":"10.1007\/s00198-007-0343-y","volume":"18","author":"JA Kanis","year":"2007","unstructured":"Kanis JA, Oden A, Johnell O et al (2007) The use of clinical risk factors enhances the performance of BMD in the prediction of hip and osteoporotic fractures in men and women. Osteoporos Int 18:1033\u20131046. \n                    https:\/\/doi.org\/10.1007\/s00198-007-0343-y","journal-title":"Osteoporos Int"},{"key":"4290_CR31","doi-asserted-by":"publisher","first-page":"1109","DOI":"10.1007\/s00198-007-0362-8","volume":"18","author":"ND Nguyen","year":"2007","unstructured":"Nguyen ND, Frost SA, Center JR et al (2007) Development of a nomogram for individualizing hip fracture risk in men and women. Osteoporos Int 18:1109\u20131117. \n                    https:\/\/doi.org\/10.1007\/s00198-007-0362-8","journal-title":"Osteoporos Int"},{"key":"4290_CR32","doi-asserted-by":"publisher","first-page":"1431","DOI":"10.1007\/s00198-008-0588-0","volume":"19","author":"ND Nguyen","year":"2008","unstructured":"Nguyen ND, Frost SA, Center JR et al (2008) Development of prognostic nomograms for individualizing 5-year and 10-year fracture risks. Osteoporos Int 19:1431\u20131444. \n                    https:\/\/doi.org\/10.1007\/s00198-008-0588-0","journal-title":"Osteoporos Int"},{"key":"4290_CR33","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1007\/s00198-014-2880-5","volume":"26","author":"K Ganda","year":"2014","unstructured":"Ganda K, Schaffer A, Seibel MJ (2014) Predictors of re-fracture amongst patients managed within a secondary fracture prevention program: a 7-year prospective study. Osteoporos Int 26:543\u2013551. \n                    https:\/\/doi.org\/10.1007\/s00198-014-2880-5","journal-title":"Osteoporos Int"},{"key":"4290_CR34","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1007\/s00198-013-2481-8","volume":"25","author":"DA Eekman","year":"2013","unstructured":"Eekman DA, van Helden SH, Huisman AM et al (2013) Optimizing fracture prevention: the fracture liaison service, an observational study. Osteoporos Int 25:701\u2013709. \n                    https:\/\/doi.org\/10.1007\/s00198-013-2481-8","journal-title":"Osteoporos Int"},{"key":"4290_CR35","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1007\/s11657-016-0258-3","volume":"11","author":"F Malgo","year":"2016","unstructured":"Malgo F, Appelman-Dijkstra NM, Termaat MF et al (2016) High prevalence of secondary factors for bone fragility in patients with a recent fracture independently of BMD. Arch Osteoporos 11:12. \n                    https:\/\/doi.org\/10.1007\/s11657-016-0258-3","journal-title":"Arch Osteoporos"},{"key":"4290_CR36","doi-asserted-by":"publisher","first-page":"241","DOI":"10.2106\/JBJS.G.00150","volume":"90","author":"S Helden van","year":"2008","unstructured":"van Helden S, van Geel AC, Geusens PP et al (2008) Bone and fall-related fracture risks in women and men with a recent clinical fracture. J Bone Joint Surg Am Vol 90:241\u2013248. \n                    https:\/\/doi.org\/10.2106\/JBJS.G.00150","journal-title":"J Bone Joint Surg Am Vol"},{"key":"4290_CR37","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1016\/j.reumae.2014.03.004","volume":"10","author":"A Naranjo","year":"2014","unstructured":"Naranjo A, Ojeda-Bruno S, Bilbao Cantarero A et al (2014) Results of a model of secondary prevention for osteoporotic fracture coordinated by rheumatology and focused on the nurse and primary care physicians. Reumatol Cl\u00edn (English Edition) 10:299\u2013303. \n                    https:\/\/doi.org\/10.1016\/j.reumae.2014.03.004","journal-title":"Reumatol Cl\u00edn (English Edition)"}],"container-title":["Osteoporosis International"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00198-017-4290-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00198-017-4290-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00198-017-4290-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,4,4]],"date-time":"2019-04-04T01:30:02Z","timestamp":1554341402000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00198-017-4290-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,11,23]]},"references-count":37,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2018,2]]}},"alternative-id":["4290"],"URL":"https:\/\/doi.org\/10.1007\/s00198-017-4290-y","relation":{},"ISSN":["0937-941X","1433-2965"],"issn-type":[{"type":"print","value":"0937-941X"},{"type":"electronic","value":"1433-2965"}],"subject":[],"published":{"date-parts":[[2017,11,23]]},"assertion":[{"value":"26 June 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 October 2017","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 November 2017","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"Dr. Vranken declares that she has no conflict of interest.Dr. Wyers declares that she has no conflict of interest.Dr. Van der Velde declares that he has no conflict of interest.Dr. Janzing declares that he has no conflict of interest.Dr. Kaarsemaker declares that he has no conflict of interest.Dr. Geusens reports grants and other from Amgen, grants from Pfizer, grants from MSD, grants from UCB, grants from Abbott, grants and other from Lilly, grants from BMS, grants from Novartis, grants from Roche, and grants from Will Pharma, outside the submitted work.Dr. Van den Bergh reports grants from Amgen, grants from Will Pharma, and grants from Eli Lilly, outside the submitted work.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}}]}}